- Home
- VC vs DNLI Comparison
VC vs DNLI Comparison
Compare VC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VC | DNLI |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VC | DNLI |
|---|---|---|
| Price | $100.75 | $21.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $126.00 | $30.82 |
| AVG Volume (30 Days) | 528.7K | ★ 1.7M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.17 | N/A |
| Revenue | ★ $3,759,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.22 | $3,897.53 |
| P/E Ratio | $9.04 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.10 | $10.57 |
| 52 Week High | $129.10 | $23.79 |
Technical Indicators
Market Signals| Indicator | VC | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 57.16 |
| Support Level | $89.68 | $19.76 |
| Resistance Level | $102.51 | $23.77 |
| Average True Range (ATR) | 3.06 | 1.40 |
| MACD | 1.06 | 0.00 |
| Stochastic Oscillator | 81.84 | 56.98 |
Price Performance
Historical ComparisonAbout VC Visteon Corporation
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.